Patents by Inventor Helen Christine Jackson

Helen Christine Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical treatment
    Publication number: 20040077730
    Abstract: A compound of formula I 1
    Type: Application
    Filed: August 15, 2003
    Publication date: April 22, 2004
    Inventors: Clifford James Bailey, Robert Brian Jones, Helen Christine Jackson
  • Medical treatment
    Patent number: 6617360
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for reducing Insulin resistance in humans in whom Impaired Glucose Tolerance and Non-Insulin Dependent Diabetes Mellitus have not presented.
    Type: Grant
    Filed: October 30, 2000
    Date of Patent: September 9, 2003
    Assignee: Knoll Aktiengesellschaft
    Inventors: Clifford James Bailey, Robert Brian Jones, Helen Christine Jackson
  • Therapeutic agents
    Patent number: 6403641
    Abstract: A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula I including enantiomers and pharmaceutically acceptable salts thereof, in which R1 and R2 are independently H or methyl, and a therapeutically effective amount of a compound of formula II wherein the compound of formula I and the compound of formula II are administered simultaneously, separately or sequentially.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: June 11, 2002
    Assignee: Abbott Labortories
    Inventors: David John Heal, Helen Christine Jackson
  • THERAPEUTIC AGENTS
    Publication number: 20020010160
    Abstract: A method for the treatment of obesity in a human in need of such treatment which comprises administration to the human of a therapeutically effective amount of a compound of formula I 1
    Type: Application
    Filed: December 16, 1998
    Publication date: January 24, 2002
    Inventors: DAVID JOHN HEAL, HELEN CHRISTINE JACKSON
  • Use of sibutramine analogues to prevent the development of diabetes
    Patent number: 6174925
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for reducing Insulin resistance in humans in whom Impaired Glucose Tolerance and Non-Insulin Dependent Diabetes Mellitus have not presented.
    Type: Grant
    Filed: March 17, 1999
    Date of Patent: January 16, 2001
    Assignee: Knoll Aktiengesellschaft
    Inventors: Clifford James Bailey, Robert Brian Jones, Helen Christine Jackson